FMC North Mountain in Phoenix, Arizona - Dialysis Center

FMC North Mountain is a medicare approved dialysis facility center in Phoenix, Arizona and it has 25 dialysis stations. It is located in Maricopa county at 16605 North 28th Avenue, Phoenix, AZ, 85053. You can reach out to the office of FMC North Mountain at (602) 863-7954. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC North Mountain has the following ownership type - Profit. It was first certified by medicare in October, 2016. The medicare id for this facility is 032647 and it accepts patients under medicare ESRD program.

Name	FMC North Mountain
Location	16605 North 28th Avenue, Phoenix, Arizona
No. of Dialysis Stations	25
Medicare ID	032647
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with FMC North Mountain from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

Dialysis patients with Hemoglobin data

6

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	19
  Adult patient months included in Kt/V greater than or equal to 1.2	109
  Percentage of adult patients getting regular hemodialysis at the center	97
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC North Mountain with elevated calcium levels.

Patients with hypercalcemia	21
Hypercalcemia patient months	121
Patients with Serumphosphor	23
Patients with Serumphosphor less than 3.5 mg/dL	9
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	21
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	24
Patients with Serumphosphor from 5.6 to 7 mg/dL	29
Patients with Serumphosphor greater than 7 mg/dL	17

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	23
Patient months included in arterial venous fistula and catheter summaries	105
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	49
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	11